Gastro-esophageal Junction Adenocarcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-02-06
Clinical Trial Update: FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial of FOLFOX-A for metastatic or unresectable gastroesophageal junction adenocarcinoma and gastric cancer has completed with resu…